PAVmed Announces PortIO Breakthrough Nasdaq
Groundbreaking i mplantable intraosseous vascular access device achieves unprecedented maintenance-free implant duration of over 60 days in.
PAVmed Announces PortIO Breakthrough Nasdaq
Groundbreaking i mplantable intraosseous vascular access device achieves unprecedented maintenance-free implant duration of over 60 days in.